Cellular Biomedicine Group

About:

CBMG is a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancers and stem cell therapies.

Website: http://cellbiomedgroup.com

Twitter/X: CellBioMedGroup

Top Investors: GIC, AstraZeneca, HongShan, YF Capital, TF Capital

Description:

Cellular Biomedicine Group is a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies. It is the result of the acquisition, transfer, commercialization, and advancement of thirty years of research and human treatment experience in cellular medicine. Its cellular research and development is the result of collaboration among scientists and doctors from the US, England, and China.